Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Federated Hermes
AddedFeb 13, 2024
UpdatedJun 28, 2026
Federated Hermes

Federated Hermes

Operating

Federated Hermes, Inc.: A global American financial firm offering asset management and investment services.

Location
Pittsburgh, PA, US
Founded
1957
Firm
Compare
Portfolio
Fundraising
Employees
Website

Federated Hermes is a global asset management firm offering a diverse range of investment products and services. The company focuses on mutual funds, annuities, and institutional separate accounts, catering to clients worldwide. Their investment approach spans various sectors and stages, from early-stage ventures to post-IPO equity rounds.

Notable portfolio companies include Alector, AvePoint, Century Therapeutics, and Taboola. Federated Hermes has demonstrated a particular interest in healthcare and technology sectors, with investments in companies like Dexcom, Insulet, and WM Technology. The firm's broad investment strategy and global reach position it as a significant player in the asset management industry.

Federated Hermes - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments21
Current Portfolio Count15
Total Portfolio Exits2

Top Investment Stages

Post Ipo Equity10 (50.0%)
Series E4 (20.0%)
Series C3 (15.0%)
Series B2 (10.0%)
Private Equity1 (5.0%)

Stage Mix

Post Ipo Equity 50%Series E 20%Series C 15%Series B 10%Private Equity 5%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Regulus Therapeutics logo

Regulus Therapeutics

Laronde logo

Laronde

Hyzon Motors logo

Hyzon Motors

AvePoint logo

AvePoint

Taboola logo

Taboola

Talkspace logo

Talkspace

WM Technology logo

WM Technology

BarkBox logo

BarkBox

Dyal Capital Partners logo

Dyal Capital Partners

NeoGenomics Laboratories logo

NeoGenomics Laboratories

Century Therapeutics logo

Century Therapeutics

Alector logo

Alector

aTyr Pharma logo

aTyr Pharma

Sanarus Medical logo

Sanarus Medical

Insulet logo

Insulet

Dexcom logo

Dexcom

Roxy.Com logo

Roxy.Com

Federated Hermes - Classification

Also Known As
  • Federated Hermes, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6200Security And Commodity Brokers, Dealers, Exchanges, And Services
  • 6280Services Allied With The Exchange Of Securities Or Commodities
  • 6282Investment Advice
ISIC
  • 6619Other activities auxiliary to financial service activities
  • 6630Fund management activities
Show 7 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523940Portfolio Management and Investment Advice
SIC
  • 5000Wholesale Trade-durable Goods
  • 6000Depository Institutions
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end